Response to: Amantadine, COVID-19 and Parkinsonism
Arch Med Res
.
2020 Oct;51(7):715.
doi: 10.1016/j.arcmed.2020.07.002.
Epub 2020 Jul 20.
Author
Gonzalo Emiliano Aranda-Abreu
1
Affiliation
1
Centro de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Veracruz, México. Electronic address: garanda@uv.mx.
PMID:
32723524
PMCID:
PMC7369578
DOI:
10.1016/j.arcmed.2020.07.002
No abstract available
Publication types
Letter
Comment
MeSH terms
Amantadine / therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Parkinsonian Disorders* / drug therapy
Pneumonia, Viral*
SARS-CoV-2
Substances
Amantadine